Terminal Complement Complex antibody [aE11]
GTX54459
ApplicationsFlow Cytometry, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
Product group Antibodies
ReactivityEquine, Human, Porcine
TargetC9
Overview
- SupplierGeneTex
- Product NameTerminal Complement Complex antibody [aE11]
- Delivery Days Customer9
- Antibody SpecificityMonoclonal antibody aE11 reacts with a C9 neoantigen of the terminal complement complex (TCC) consisting of C5B, C6, C7, C8, C9 (PubMed ID: 4035298). The TCC contains neoantigens that are absent from the individual native components.- C9 neoantigens are p
- Application Supplier Note*Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDaE11
- Concentration100 ug/ml
- ConjugateUnconjugated
- Gene ID735
- Target nameC9
- Target descriptioncomplement C9
- Target synonymsARMD15; C9D; complement component 9; complement component C9
- HostMouse
- IsotypeIgG2a
- Protein IDP02748
- Protein NameComplement component C9
- Scientific DescriptionThis gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009]
- ReactivityEquine, Human, Porcine
- Storage Instruction2°C to 8°C
- UNSPSC12352203